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Virulence mechanisms underlying Helicobacter pylori persistence and disease remain
poorly understood, in part, because the factors underlying disease risk are multifactorial
and complex. Among the bacterial factors that contribute to the cumulative
pathophysiology associated with H. pylori infections, the vacuolating cytotoxin (VacA) is
one of the most important. Analogous to a number of H. pylori genes, the vacA gene
exhibits allelic mosaicism, and human epidemiological studies have revealed that several
families of toxin alleles are predictive of more severe disease. Animal model studies
suggest that VacA may contribute to pathogenesis in several ways. VacA functions as
an intracellular-acting protein exotoxin. However, VacA does not fit the current prototype
of AB intracellular-acting bacterial toxins, which elaborate modulatory effects through
the action of an enzymatic domain translocated inside host cells. Rather, VacA may
represent an alternative prototype for AB intracellular acting toxins that modulate cellular
homeostasis by forming ion-conducting intracellular membrane channels. Although VacA
seems to form channels in several different membranes, one of the most important
target sites is the mitochondrial inner membrane. VacA apparently take advantage of an
unusual intracellular trafficking pathway to mitochondria, where the toxin is imported and
depolarizes the inner membrane to disrupt mitochondrial dynamics and cellular energy
homeostasis as a mechanism for engaging the apoptotic machinery within host cells.
VacA remodeling of the gastric environment appears to be fine-tuned through the action
of the Type IV effector protein CagA which, in part, limits the cytotoxic effects of VacA in
cells colonized by H. pylori.
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Helicobacter pylori AND VacA
Virulence mechanisms underlying Helicobacter pylori-mediated
gastric maladies have remained enigmatic, in part, because dis-
ease risk is multifactorial and complex (Compare et al., 2010;
Polk and Peek, 2010). However, several bacterial factors clearly
contribute to the pathophysiology associated with H. pylori infec-
tions (Fischer et al., 2009), and one of the most important is the
vacuolating cytotoxin (VacA) (Cover and Blanke, 2005).
Since the discovery of VacA nearly 25 years ago as the pro-
teinacious factor within H. pylori culture filtrates that intoxicates
epithelial cells and induces vacuole biogenesis (Leunk et al.,
1988), the study of this toxin has been challenging in part, because
the toxin possesses a number of surprising and unusual character-
istics that don’t fit neatly into current concepts of bacterial toxins.
Nonetheless, several interesting and important properties of VacA
have become apparent. First, the gene encoding VacA (vacA) is
characterized by a high degree of genetic variation; strains with
specific allelic variants of vacA that exhibit greater levels of VacA-
mediated cytotoxic activity in vitro are associated with a greater
risk of gastric disease in H. pylori-infected humans. Moreover,
experimental evidence supports the idea that VacA may promote
H. pylori colonization, persistence, and infection-associated dis-
ease pathophysiology.
STRUCTURAL PROPERTIES OF VacA
H. pylori synthesize VacA as an approximately 140 kDa pre-
protoxin (Figure 1), which undergoes sequential proteolytic pro-
cessing during Type Va secretion as an auto-transporter protein
(Fischer et al., 2001). The secreted mature form of VacA is a
88 kDa monomer (Cover and Blaser, 1992), that is purified from
H. pylori growth medium (Gonzalez-Rivera et al., 2010) as water-
soluble hexameric or heptameric rings (Figure 1) in single or
bilayered structures (Figure 1) (Lupetti et al., 1996; Cover et al.,
1997; Lanzavecchia et al., 1998; Czajkowsky et al., 1999; Adrian
et al., 2002; El-Bez et al., 2005). Acidic or alkaline pH pro-
motes dissociation of VacA oligomeric complexes into monomers
(Cover et al., 1997;Molinari et al., 1997; Yahiro et al., 1997), which
is likely the form of the toxin to bind host cells during infection
(Gonzalez-Rivera et al., 2010).
The mature 88 kDa form of the toxin is sometimes detected
as a proteolytically-nicked protein, comprising two domains des-
ignated p33 (residues 1–311) and p55 (residues 312–821), that
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FIGURE 1 | VacA structure. (A) Schematic VacA structure. Each domain is
denoted by a different color and by the first and last amino residue of that
particular domain. The name of each domain is denoted in bold, and its
function (if known) is described. (B) The polymorphic nature of the vacA gene
is emphasized by highlighting the three major allele families, which are
located in the signal region (s region), the intermediate region (i region), and
the mid-region (m region). (C) The proposed structure of the VacA oligomeric
assembly, based on the crystal structure of a portion of p55 [Gangwer et al.
(2007)] and electron microscopy imaging of VacA oligomers [El-Bez et al.
(2005)].
remain non-covalently associated (Figure 1A) (Telford et al.,
1994; Cover et al., 1997; Ye et al., 1999; Nguyen et al., 2001;
Willhite et al., 2002; Torres et al., 2004, 2005). Recently, a crystal
has been solved for p55 (Gangwer et al., 2007), revealing a pre-
dominantly right-handed parallel beta-helix structure, which is
typical for autotransporter passenger domains. High-resolution
structural data for p33 are not yet available. Proteolytic cleavage
into discrete functional domains is a characteristic of a number of
so-called intracellular-acting AB toxins (Blanke, 2005). However,
proteolytic cleavage of VacA into p33 and p55 is apparently not
required for VacA activity (Burroni et al., 1998). While neither
p33 nor p55 alone are sufficient to induce vacuole biogenesis,
the cellular activity of VacA can be reconstituted from two sep-
arate recombinant proteins added exogenously (Gonzalez-Rivera
et al., 2010) or expressed ectopically within cultured cells (Ye
et al., 1999; Ye and Blanke, 2000; Willhite et al., 2002; Ye and
Blanke, 2002). All of p33 and approximately the amino-terminal
100 residues of p55 are apparently required to induce vacuola-
tion, revealed when a fragment comprising VacA residues 1–422,
but not a fragment comprising residues 1–394, induced cellular
vacuolation when expressed in transiently transfected cells (de
Bernard et al., 1997, 1998; Ye et al., 1999).
The association of p33 or p55 with discrete toxin functions
remains poorly understood. Several lines of evidence suggest that
p55 possesses a domain important for binding the toxin to the
cell surface (Pagliaccia et al., 1998; Reyrat et al., 1999; Wang
and Wang, 2000; Wang et al., 2001). However, the binding of
p55 to cells appears to be considerably weaker than that of full-
length VacA. Moreover, p33 appears to also contribute to VacA
cell surface binding (Torres et al., 2005; Gonzalez-Rivera et al.,
2010).
The amino-terminal 34 residues of p33 domain comprise what
is predicted to be a highly hydrophobic domain, which has been
implicated to be critical for the capacity of VacA to form ion-
conducting channels (Vinion-Dubiel et al., 1999; Ye and Blanke,
2000; McClain et al., 2003). As discussed below, VacA chan-
nels are probably the biochemical activity most critical for the
cellular modulating activity of the toxin. However, deletion of
part of this region (residues 1–27) resulted in a mutant form of
VacA that also demonstrated some channel activity in planar lipid
bilayers, albeit requiring a significantly longer time to for chan-
nel formation (Vinion-Dubiel et al., 1999), suggesting that the
hydrophobic amino-terminus is not absolutely required for VacA
channel activity. More recently, channel activity in planar lipid
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bilayers was also demonstrated for a mutant form of p33 lack-
ing residues 1–37 (Domanska et al., 2010). Thus, the molecular
basis underlying VacA channel formation, at least in artificial lipid
bilayers, remains to be clarified.
INTRACELLULAR MEMBRANE CHANNEL FORMATION
BY VacA: THE TRUE BIOCHEMICAL ACTIVITY OF VacA?
Analogous to many other bacterial toxins, VacA is able to
insert into membranes and form ion-conducting channels
(Czajkowsky et al., 1999, 2005; Tombola et al., 1999a,b, 2001b).
Characterization of VacA channels has revealed slight anion selec-
tivity (Czajkowsky et al., 1999; Iwamoto et al., 1999; Tombola
et al., 1999a,b, 2001b) and several electrophysiological proper-
ties that are similar to some anion-selective channels found in
human cells (Campello et al., 2002; Czajkowsky et al., 2005).
Electron microscopy images of membrane-associated VacA have
revealed primarily hexagonal ring-shaped structures (Czajkowsky
et al., 1999; Adrian et al., 2002; Geisse et al., 2004) that likely cor-
respond to VacA channels or a pre-channel form of the toxin,
although direct evidence is lacking for both of these possibili-
ties. Based on studies indicating that both VacA binding to lipid
membranes (Czajkowsky et al., 1999) and channel formation
(Czajkowsky et al., 1999; Iwamoto et al., 1999; Geisse et al., 2004)
are enhanced by acid-activation of the toxin support a model that
VacA binds to the membrane surface as a monomer, and subse-
quently undergoes assembly into higher-ordered structures and
membrane insertion.
VacA channel activity has been associated with a number of
the toxin’s cellular modulatory effects. The exact nature of cell
modulation is apparently dependent on the site of channel for-
mation. The release of cellular ions and small organic molecules
has been attributed to VacA channel formation at the plasma
membrane (Szabo et al., 1999; Tombola et al., 2001a). Cellular
vacuolation is been ascribed to VacA channels within endocytic
compartments (Montecucco and Rappuoli, 2001). VacA chan-
nel formation within the inner membranes of mitochondria
(Galmiche et al., 2000; Willhite and Blanke, 2004; Calore et al.,
2010; Domanska et al., 2010) is believed to be the biochemical
activity of the toxin responsible for depolarization of the inner
membrane (Kimura et al., 1999; Willhite and Blanke, 2004) and
disruption of mitochondrial dynamics, ultimately responsible for
inducing cell death (Jain et al., 2011).
THE RELATIONSHIP BETWEEN vacA GENETIC
DIVERSITY AND DISEASE
Understanding the importance of VacA for H. pylori-mediated
disease is not as straightforward as demonstrating the correla-
tion between the presence or absence of the vacA gene in human
isolates and the incidence of gastric disease. Indeed, the very ear-
liest studies revealed that the vacA gene is present in essentially all
human isolates. Further study revealed in short order that not all
vacA genes are identical.
THE ALLELIC DIVERSITY OF vacA
Although essentially all H. pylori strains carried a vacA gene, the
levels of vacuolating activity with bacterial culture filtrates were
found to be markedly different from strain to strain (Leunk et al.,
1988; Figura et al., 1989; Cover et al., 1990, 1993; Cover and
Blaser, 1992). Several reasons underlying the diversity in vacuo-
lating activity among H. pylori strains were discovered. H. pylori
isolates were identified that carried non-sense mutations, internal
duplications, deletions, or 1 bp insertions within the vacA gene
(Ito et al., 1998). Differences in the transcription of vacA or the
efficiency in VacA secretion have also been found to influence
the levels of vacuolating activity with H. pylori culture filtrates
(Forsyth et al., 1998). Perhaps the most important reason, how-
ever, for differences in vacuolating activity between differences in
strains is variation discovered in the VacA amino acid sequences
(Atherton et al., 1995), which subsequently have been associ-
ated with the observed divergence in cellular vacuolating activity
(Figure 1A) (Atherton et al., 1995; Strobel et al., 1998; van Doorn
et al., 1998). The vacA genotype is recognized as an important
determinant of the toxin’ cellular activity.
The maximum amount of sequence diversity is found in
several defined regions of vacA (Figure 1A). The middle of
vacA, which was named the “m (for middle) region,” encodes
an approximately 800 bp region in the carboxyl-terminal p55
domain of VacA. Within the m region, the two primary allelic
families that are differentiated among strains are called m1 and
m2 (Atherton et al., 1995, 1999; Pagliaccia et al., 1998; Ji et al.,
2002). Sequence diversity within the m-alleles of vacA has been
functionally associated with differences in cell tropism between
VacA proteins (Pagliaccia et al., 1998; Ji et al., 2000; Wang et al.,
2001). There is some evidence to indicate that the differences
in cell type specificities demonstrated for the s1/m1 and s1/m2
forms of VacA may be due to, at least in part to distinct cell
binding properties (Pagliaccia et al., 1998; Ji et al., 2000; Wang
et al., 2001). The VacA determinants that influence the cell-type
specificities demonstrated for the m1 and m2 forms of VacA have
been mapped to a 148-residue region within p55 (Ji et al., 2000;
Skibinski et al., 2006). However, the entire m-region is apparently
essential for cell surface binding and vacuolating activity of the
toxin (Wang and Wang, 2000; Skibinski et al., 2006).
The amino-terminal end of VacA, designated as the “s region,”
also demonstrates considerable sequence diversity, which extends
from the signal sequence that directs secretion across the bacte-
rial inner membrane into the amino terminus of the processed
mature toxin (Figure 1A) (Atherton et al., 1995; Strobel et al.,
1998; van Doorn et al., 1998). The two primary allelic groups that
have been differentiated among strains are referred to as s1 and s2,
and the s1 group further differentiates into the s1a, s1b, and s1c
subtypes. Notably, sequence differences between strains carrying
the s1 or s2 alleles correspond directly to functional differences, as
strains carrying the s2 vacA allele fail to induce cellular vacuola-
tion (Atherton et al., 1995). Analysis of s2 forms of vacA revealed
that the signal sequences of these proteins are processed at a dif-
ferent cite, resulting in a mature form of VacA with a 12 amino
acid extension that inactivates the toxin (Letley and Atherton,
2000; McClain et al., 2001; Letley et al., 2003).
Most recently, a third region of sequence diversity, called the
“i (for intermediate) region” has been identified in the carboxyl-
terminal half of p33 between the s and m regions of VacA (Rhead
et al., 2007). Three primary i-region types (i1, i2, and i3) (Chung
et al., 2010) have been identified and revealed to be associated
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with the divergent vacuolating activities associated with different
forms of the toxin. Although the structure-function relationships
underlying the contributions of the i-region to the cellular activ-
ity of VacA have not been identified, i1 vacA strains were found
to have the strongest vacuolating activity on mammalian cells.
The i region has been proposed to be a more reliable predictor
of severe gastric disease than the s- or m-regions of the vacA gene,
and i1 strains are strongly associated with gastric adenocarcinoma
and peptic ulcer disease (Rhead et al., 2007; Basso et al., 2008).
THE ASSOCIATION OF vacA GENOTYPES WITH DISEASE
Efforts to evaluate potential roles of VacA in the pathogenesis of
human gastroduodenal diseases are complicated by the multifac-
torial nature ofH. pylori pathophysiology in the human stomach.
Nonetheless, epidemiology studies have been extremely useful for
demonstrating a correlation between particular vacA i-, m-, and
s-region allelic types and occurrence and severity of disease in
H. pylori-infected humans. Many studies have provided evidence
for a higher association of disease in individuals infected with
H. pylori strains possessing s1 vacA alleles encoding toxin vari-
ants with greater cellular activity in vitro than strains with s2
vacA alleles (Atherton et al., 1995, 1997; Han et al., 1998; Rudi
et al., 1998; Strobel et al., 1998; van Doorn et al., 1998, 1999;
Gerhard et al., 1999; Kidd et al., 1999; de Gusmao et al., 2000).
In addition, strains with s1 alleles are a higher risk for gastric
carcinoma than strains harboring vacA s2 alleles (Miehlke et al.,
2000; Ashour et al., 2002; Figueiredo et al., 2002). As far as the
m region, H. pylori strains harboring m1 vacA alleles have been
more highly associated with gastric carcinoma (Miehlke et al.,
2000; Ashour et al., 2002; Figueiredo et al., 2002), as well as
gastric alterations that normally precede the onset of gastric can-
cer, including epithelial damage, atrophic gastritis, and intestinal
metaplasia (Atherton et al., 1997; Nogueira et al., 2001), than
are those strains with m2 vacA alleles. Strains carrying both the
s1 (Atherton et al., 1995; Rudi et al., 1998; Vinion-Dubiel et al.,
1999; Ye and Blanke, 2000) and the m1 allele (Pagliaccia et al.,
1998; Ji et al., 2000; Letley et al., 2003; Skibinski et al., 2006),
are strongly associated with increased bacterial load and PMN
infiltration within human gastric mucosa (Hofman et al., 2007),
duodenal and gastric ulceration (Atherton et al., 1995, 1997; Rudi
et al., 1998; Strobel et al., 1998; Figueiredo et al., 2001) and gas-
tric cancer (Basso et al., 1998; Evans et al., 1998; Kidd et al., 1999;
Miehlke et al., 2000; Figueiredo et al., 2001). As discussed above,
more recent studies have suggested the possibility that the iden-
tity of the i allele may be the most reliable predictor of severity
of disease, with the i1 allele predictive of the most severe disease
outcome (Rhead et al., 2007).
PROPERTIES OF VacA RELATED TO H. pylori
COLONIZATION AND DISEASE
H. pylori have co-evolved along with humans, and thus the use
of existing rodent and non-human primate models for studying
bacterial colonization and gastric disease would be predicted to
have limitations. Nonetheless, animal studies have been valuable
for revealing that VacA may contribute to H. pylori pathogen-
esis in several ways. Administration of purified toxin within a
mouse model induces the degeneration of the gastric mucosa,
inflammatory cell recruitment, and the formation of gastric
lesions resembling the pathology observed in humans (Telford
et al., 1994; Ghiara et al., 1995; Marchetti et al., 1995; Fujikawa
et al., 2003). VacA has been implicated as a contributing factor
within a Mongolian gerbil disease model (Ogura et al., 2000).
VacA promotes H. pylori colonization within a mouse infection
model (Salama et al., 2001). More recently, several studies sug-
gested that VacA may contribute to H. pylori subversion of the
host’s immune response through elaboration of several immuno-
suppressive activities (Montecucco and de Bernard, 2003; Fischer
et al., 2004). An enormous body of work supports the impor-
tance of VacA in H. pylori-mediated human disease. In contrast,
the molecular and cellular basis by which VacA interacts with and
modulates human cells remains poorly understood.
VacA AS A CELLULAR MODULATOR: THE MULTIPLE
CONSEQUENCES OF VacA INTOXICATION
In an effort to understand how VacA contributes to H. pylori
colonization of the stomach and development of gastroduodenal
disease, the effects of VacA on human cells have been investi-
gated in vitro. VacA is able to intoxicate a wide range of cell types,
including gastric epithelial cells and several types of immune
cells, resulting in an array of multiple different cellular alterations
(Figure 2).
The published modulatory effects of VacA on epithelial and
immune cells will be discussed briefly. In contrast, recent evi-
dence implicating VacA as a mitochondrial-targeting toxin will
be considered in more detail.
VacA MODULATION OF EPITHELIAL CELL FUNCTION
The first documented (Leunk et al., 1988; Smoot et al., 1996;
Pagliaccia et al., 1998) cellular activity of VacA was the capac-
ity to induce the biogenesis of large intracellular vacuoles that
occupy almost the entire epinuclear region (Figure 2B). VacA-
mediated vacuolar compartments are acidic (Cover et al., 1991),
enriched in the small GTPase Rab7 as well as other late endocytic
markers (Papini et al., 1994, 1996, 1997; Molinari et al., 1997;
Li et al., 2004), and exclude trypan blue (Leunk et al., 1988),
indicating that vacuolation per se is not a cytolethal response
to VacA intoxication. Vacuolation may be due to toxin-mediated
alterations in the trafficking of endocytic vesicles, as indicated
by VacA-dependent inhibition of the intracellular degradation
of epidermal growth factor, and inhibition of procathepsin D
maturation (Satin et al., 1997).
The capacity of VacA to form anion-conducting channels is
important for the biogenesis of vacuoles (Szabo et al., 1999;
Tombola et al., 1999b; Vinion-Dubiel et al., 1999; Ye and Blanke,
2000; McClain et al., 2003; Genisset et al., 2007), which then
swell further in the presence of membrane permeable weak bases
(Czajkowsky et al., 1999; Szabo et al., 1999; Tombola et al., 1999b;
Morbiato et al., 2001). The sources of membrane required for
the formation of the large intracellular vacuoles remains unclear.
The demonstration that the SNARE protein syntaxin 7, which
is involved in intracellular membrane fusion events, is local-
ized to the membranes of VacA-induced vacuoles supports a
model that VacA-induced vacuoles may result from the fusion
of multiple smaller endocytic compartments (Gauthier et al.,
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FIGURE 2 | Modulation of gastric cell functions by VacA. (A) Distribution
of H. pylori at the gastric epithelium. Approximately 80% of H. pylori localize
to the layer of mucus overlaying the epithelial membrane, while the
remainder attach to the membrane surface as microcolonies. (B) VacA binds
to epithelial cell surface receptors (SM, RPTP-a/β), and is taken up by a
Cdc42-dependent, pinocytic-like mechanism into (GPI)-enriched early
endosomal compartments (GEECs) followed by F-actin-dependent transport
to early and late endosomal compartments (EE and LE). LE fusion with
lysosomes (L) promotes vacuole biogenesis in a manner dependent on VacA
(Continued)
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FIGURE 2 | Continued
channel activity. VacA was recently reported to induce the formation of
autophagosomes (AP), which typically mature to autophagolysosomes (AL).
(C) A portion of VacA-containing EEs/LEs are transported to mitochondria
within Bax-enriched vesicles. VacA channel formation within the
mitochondrial inner membrane induces depolarization, m dissipation, and
disruption of mitochondrial dynamics at the level of Drp1-dependent fission,
triggering Bax permeabilization of the mitochondrial outer membrane and
cytochrome c release, resulting in apoptosis. VacA-mediated downregulation
of Bcl-2/Bcl-xL [Matsumoto et al. (2011)] also promotes cell death. (D) VacA
has been proposed to promote cellular proliferation via p38 activation, which
increases ATF-2 regulated expression of prostaglandin E2 (PGE2) [Hisatsune
et al. (2007)], as well as the activation of β-catenin though the deregulation of
phosphorylation of glycogen synthase kinase 3 (GSK3β) and Akt, initiated by
the activation of phosphoinositide 3-kinase (PI3K) [Nakayama et al. (2009)].
Histamine secretion stimulated by VacA inhibits HCO3− mediated protection
against acid and pepsin [Tuo et al. (2009)]. (E) VacA induces the influx of
Ca2+ into parietal cells, thereby activating calpain 1, a protease that degrades
ezrin, an actin binding protein that is critical for proton release [Wang et al.
(2008)], thereby deregulating acid secretion machinery within parietal cells in
a manner that may promote H. pylori persistence. (F) VacA channel formation
in the apical membrane surface may expose H. pylori to diffusible nutrients
such as amino acids, sugar, and metal ions [Szabo et al. (1999); Debellis et al.
(2001); Montecucco and Rappuoli (2001); Tombola et al. (2001a)]. H. pylori
urease may convert released urea into ammonia which neutralizes acid,
which inhibits activation of pepsinogen to pepsin, eventually causing
dyspepsia [Mobley et al. (1995); Carter et al. (2009)]. (G) VacA-dependent
remodeling of H. pylori -containing vacuoles facilitates bacterial survival within
macrophages [Zheng and Jones (2003)]. (H) VacA stimulates the release of
secretory granules within mast cell by causing the oscillation of intracellular
Ca2+ levels [de Bernard et al. (2005)]. VacA intoxication of monocytes results
in Ca2+-dependent p38 activation, leading to proinflammatory cytokine
production via ATF-2, CREB, and NF-κB-dependent mechanisms [Hisatsune
et al. (2008)]. Within eosinophils, VacA deregulates ROS intermediates (ROI)
and intracellular Ca2+ to stimulate proinflammatory cytokine release by a
NF-κB-dependent mechanism [Kim et al. (2007)]. (I) In T cells, VacA
recognized by CD18, blocks Ca2+ influx, the activation of calcineurin, and
nuclear factor of activated T-cells (NFAT) a transcription factor required for the
expression of interleukin-2 (IL-2), ultimately suppressing T-cell proliferation
[Sewald et al. (2008)]. VacA recognized by lymphocyte function-associated
antigen 1 (LFA-1) receptor activates mitogen-activated protein kinase kinase
3/6 (MKK3/6), leading to the activation of p38 and Rac 1, resulting in the
cytoskeletal change [Sewald et al. (2008)]. In B cells, VacA disrupts antigen
presentation of MHC II.
2007). Conversely, several other studies instead support a model
of swelling of the internal membranes of the late endosomal
compartments (de Bernard et al., 2002; Genisset et al., 2007).
Despite intensive study into the molecular basis and mecha-
nism underlying vacuole biogenesis in VacA intoxicated cells, it
remains poorly understood whether vacuolation per se directly
contributes toH. pylori colonization, persistence or disease patho-
physiology. Alternatively, vacuolation may represent the general
stress response of cells intoxicated with VacA.
Modulatory effects of VacA on cell viability
Sustained infection with H. pylori results in alterations within in
the gastric mucosa that have been associated with the progression
of infection to gastric disease. As mentioned above, VacA alone
is sufficient to damage the gastric mucosa of mice (Telford et al.,
1994; Ghiara et al., 1995; Marchetti et al., 1995; Fujikawa et al.,
2003). A hallmark ofH. pylori infection is increased level of apop-
tosis in human gastric mucosa (Mannick et al., 1996; Moss et al.,
1996; Jones et al., 1997; Wagner et al., 1997; Fan et al., 1998), mice
(Jones et al., 2002), and Mongolian gerbil models (Peek et al.,
2000).
Increased cell death within the epithelial membrane may con-
tribute to H. pylori disease pathogenesis in several ways (Correa
and Houghton, 2007). Increased apoptosis may alter the gas-
tric environment to promote H. pylori persistence (Cover and
Blanke, 2005), while at the same time, contribute to gastric dis-
ease, including peptic ulcers and gastric adenocarcinoma (Cover
and Blaser, 2009). Although several H. pylori factors (Peek et al.,
1999; Kawahara et al., 2001) have been implicated as mediators of
cell death, VacA is per se sufficient to induce cell death (Figure 2C)
(Boquet et al., 2003; Cover et al., 2003). VacA-mediated cell death
is apparently complex, involving cellular alterations that are con-
sistent with both apoptotic (Kuck et al., 2001; Boquet et al., 2003;
Cover et al., 2003; Willhite et al., 2003; Oldani et al., 2009) and
necrotic (Willhite and Blanke, 2004; Radin et al., 2011) cell death
programs.
Modulatory effects of VacA on signaling transduction pathways
regulating cellular homeostasis
VacA-mediated cellular vacuolation is typically observed within
several hours after addition of VacA to cells. However, VacA
causes several cellular effects that can be detected at much ear-
lier time points. Within 10min after addition of VacA to a
human gastric adenocarcinoma cell line (AZ-521), two classes
of mitogen-activated protein (MAP) kinases (p38 and ERK1/2)
and the activating transcription factor 2 (ATF-2) signaling path-
way were reported to be activated (Figure 2D) (Nakayama et al.,
2004; Hisatsune et al., 2007). An inhibitor of p38 kinase activity
(SB203580) does not block VacA-induced vacuolation or VacA-
induced cytochrome c release, which indicates that VacA-induced
activation of the p38/ATF-2 signal pathway is independent of
VacA effects on late endocytic compartments and mitochon-
dria (Nakayama et al., 2004). One reported consequence of
VacA-induced p38 activation is upregulation of cyclooxygenase-2
(COX-2) expression, leading to increased PGE2 production
(Figure 2D) (Hisatsune et al., 2007). In addition to effects of
VacA on MAP kinases, VacA is reported to activate a signaling
pathway involving tyrosine phosphorylation of the G protein-
coupled receptor kinase interactor (Git1) (Fujikawa et al., 2003)
and a signaling pathway that leads to upregulated expression of
vascular endothelial growth factor (Caputo et al., 2003).
In contrast to effects of VacA on endocytic compartments
and mitochondria, the relatively rapid cellular responses to VacA
described above are likely to be the consequences of VacA inter-
actions with specific cell surface components, without a require-
ment for internalization of the toxin. The cell surface receptors
for VacA that are involved in activating MAP kinase signaling
pathways have not yet been characterized. Activation of the Git1
pathway is dependent on VacA binding to RPTP-β (Fujikawa
et al., 2003). VacA-induced upregulation of vascular endothelial
growth factor reportedly occurs through a pathway involving acti-
vation of epidermal growth factor receptor, MAP kinases, and
COX-2 (Caputo et al., 2003).
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Modulatory effects of VacA on epithelial monolayer
permeability/nutrient acquisition
VacA has been reported to lower the trans-epithelial electric resis-
tance (TER) of monolayers formed by several different types of
polarized epithelial cells, an effect that is attributable to increased
paracellular epithelial permeability of the monolayers to low
molecular mass molecules and ions (Figure 2F) (Papini et al.,
1997). Selective permeabilization of epithelial monolayers by
VacA has been proposed to support the growth of H. pylori in
the gastric mucus layer by promoting the release of factors such
as Fe3+, Ni2+, sugars, and amino acids (Papini et al., 1997).
The mechanisms by which VacA alters paracellular permeability
are not yet well understood. This activity does not require acid-
activation of purified oligomeric VacA, and is not inhibited by
bafilomycin A1.
VacA also been reported to increase the transepithelial flux of
certain molecules, including urea and bicarbonate (Figure 2E)
(Guarino et al., 1998; Szabo et al., 1999; Debellis et al., 2001;
Tombola et al., 2001a). Transepithelial flux of these molecules is
attributed to the formation of VacA channels in the plasma mem-
brane (Szabo et al., 1999). Bicarbonate release has been suggested
to promote bacterial survival within the acidic gastric mucus
layer, and release of urea may optimize the enzymatic activity
of H. pylori urease. Most recently, VacA has been demonstrated
to cause mislocalization of the transferrin receptor to the api-
cal membrane of polarized monolayers, thereby facilitating iron
acquisition from interstitial holotransferrin to H. pylori micro-
colonies attached to the apical membrane (Tan et al., 2011).
Modulatory effects of VacA on the cytoskeleton
VacA-mediated cytoskeletal alterations in both actin filaments
and the microtubule system have been reported (Ashorn et al.,
2000; Pai et al., 2000; Tabel et al., 2003; Yuan et al., 2004; Hennig
et al., 2005; Wang et al., 2005). Studies emerging from a yeast
two-hybrid screen suggested that, at least in this system, VacA
interacted with an intermediate filament interacting protein (de
Bernard et al., 2000). Moreover, VacA may alter the expression of
multiple cytoskeletal-related genes (Pai et al., 2000; Yuan et al.,
2004; Wang et al., 2005), although the mechanisms underlying
these cytoskeletal alterations have not been demonstrated.
More recently, VacA intoxication of parietal cells was reported
to prevent the recruitment of H,K-ATPase-containing tubulovesi-
cles to the apical membrane (Figure 2E), thereby disrupting api-
cal membrane-cytoskeletal interactions (Wang et al., 2008). The
disruption in the radial arrangement of actin filaments in api-
cal microvilli was found to be due to the loss of ezrin integrity.
The authors proposed that the proteolysis of ezrin in VacA-
infected parietal cells represents a novel mechanism underlying
H. pylori-induced inhibition of acid secretion, thereby resulting
in hypochlorhydria.
Modulatory effects of VacA in promoting intracellular survival of
H. pylori in gastric epithelial cells
The importance of an intracellular reservoir of H. pylori dur-
ing persistent gastric infection has been debated. While there is
now consensus that H. pylori are found primarily in the mucus
layer overlying gastric epithelial cells within humans, with the
remainder on the apical surface of the epithelial membrane, there
is evidence that the bacteria might occasionally localize within
gastric epithelial cells. Several studies have suggested that VacA
might promote survival of H. pylori within gastric epithelial
cells (Bjorkholm et al., 2000; Petersen et al., 2001). VacA was
shown to promote intracellular survival of H. pylori via a mecha-
nism involving VacA-dependent retention of Rab7, fusion of late
endocytic compartments, and sequestration H. pylori-containing
cell compartments away from the lysosomal degradative pathway
(Terebiznik et al., 2006). In contrast, another study did not detect
a role of VacA in intracellular survival of H. pylori (Amieva et al.,
2002).
Modulatory effects of VacA resulting in the induction of autophagy
Recently, VacA was demonstrated to induce autophagic signaling
within intoxicated epithelial cells (Figure 2B) (Terebiznik et al.,
2009; Raju et al., 2012). The autophagic vesicles and vacuoles
induced within VacA intoxicated cells are apparently not the
same vesicles. While the role of autophagy during H. pylori infec-
tion is currently unclear, autophagy might function to limit the
toxin-mediated cellular cytotoxicity (Terebiznik et al., 2009).
VacA AS A MODULATOR OF IMMUNE CELL FUNCTION
Beyond the well-documented effects of VacA on epithelial cells,
additional roles for the toxin in modulating the properties of T
lymphocytes have been demonstrated (Figure 2H) (Boncristiano
et al., 2003; Gebert et al., 2003; Sundrud et al., 2004; Oswald-
Richter et al., 2006; Algood et al., 2007). VacA inhibits Jurkat
T cell production of interleukin 2 (IL-2), which promotes T
cell viability and proliferation, as well as down-regulates surface
expression of the IL-2 receptor (Boncristiano et al., 2003; Gebert
et al., 2003; Sundrud et al., 2004), by inhibiting activation of
nuclear factor of T cells (NFAT) (Boncristiano et al., 2003; Gebert
et al., 2003), a transcriptional regulator required for optimal
T cell activation. VacA inhibits NFAT activation by a mecha-
nism involving the blocking of calcium influx into cells from the
extracellular milieu, thereby inhibiting the activity of the Ca2+-
calmodulin-dependent phosphatase calcineurin (an enzyme that
dephosphorylates NFAT) (Boncristiano et al., 2003; Gebert et al.,
2003).
In contrast to what was reported for Jurkat T cells VacA intoxi-
cation primary humanCD4+T cells inhibited the proliferation of
activated cells, inducedmitochondrial depolarization, ATP deple-
tion, and cell cycle arrest (Sundrud et al., 2004; Oswald-Richter
et al., 2006). Moreover, VacA also inhibits activation-induced pro-
liferation of human CD8 + T cells and B cells (Torres et al.,
2007). The immunomodulatory actions of VacA on T- and B-
lymphocytes suggest the possibility that VacA might contribute
to the ability of H. pylori to establish a persistent infection in the
human gastric mucosa.
Interestingly, the effects of VacA on T cells may occur via more
than one mechanism. While some effects are dependent on the
formation of VacA channels in cell membranes (Boncristiano
et al., 2003; Sundrud et al., 2004; Oswald-Richter et al., 2006),
others are the result of activation of intracellular signaling in T
cells, via a channel-independent mechanism (Boncristiano et al.,
2003). It is hypothesized that VacA enters the lamina propria via
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disruptions in the gastric epithelial layer, and thereby intoxicates
T cells and various other types of immune cells. In addition,
it is possible that VacA may target intraepithelial T lympho-
cytes. Most of the effects of VacA on T lymphocytes described
above are expected to result in localized immunosuppression.
VacA also stimulates expression of COX-2, a proinflamma-
tory enzyme, in T lymphocytes, which is expected to have a
proinflammatory effect (Boncristiano et al., 2003). Thus, the
effects of VacA on immune cells are complex, and are char-
acterized by both immunostimulatory and immunosuppressive
actions.
MODULATORY EFFECTS OF VacA ON ANTIGEN PRESENTATION
VacA has been reported to interfere with the process of antigen
presentation by B lymphocytes (Figure 2I). In one model system,
VacA interfered with proteolytic processing of tetanus toxoid and
inhibited the invariant chain (Ii)-dependent pathway of antigen
presentation mediated by newly synthesized major histocompat-
ibility complex (MHC) class II molecules (Molinari et al., 1998).
This effect of VacA on antigen-presenting cells is likely due to
VacA-induced effects on endocytic compartments, resulting in
alterations in endocytic trafficking.
MODULATORY EFFECTS OF VacA ON ANTIGEN MACROPHAGES
Two reports provided evidence that VacA contributes to the for-
mation of large vesicular compartments (termed megasomes)
in H. pylori-infected macrophages by stimulating homotypic
phagosome fusion (Allen et al., 2000; Zheng and Jones, 2003).
VacA stimulates the recruitment and retention of the trypto-
phan aspartate-containing coat protein (TACO or coronin 1)
to phagosomes, thereby disrupting proper vesicular maturation
(Zheng and Jones, 2003), which in turn, may impair phago-
cytic killing of H. pylori. Notably, one report did not detect any
effects of VacA on phagosome formation or intracellular survival
of H. pylori in human monocytes (Rittig et al., 2003). In addi-
tion to having effects on vesicular compartments in macrophages,
VacA also is reported to stimulate activation of p38 MAP
kinase and cause increased expression of COX-2 in macrophages
(Boncristiano et al., 2003). Finally, it has been reported that VacA
may contribute to the apoptosis of macrophages infected with
H. pylori (Menaker et al., 2004).
MODULATORY EFFECTS OF VacA ON MAST CELLS,
EOSINOPHILS, AND NEUTROPHILS
Incubation of VacA with mast cells stimulates production of
pro-inflammatory cytokines and induces mast cell chemotaxis
(Figure 2G) (Supajatura et al., 2002; de Bernard et al., 2004).
Binding of VacA to a mast cell line (RBL-2H3 cells) induces an
oscillation in levels of cytosolic calcium and exocytosis of secre-
tory granules (de Bernard et al., 2004). The rapid changes in
calcium concentration that follow VacA interaction with mast
cells may result from VacA interactions with cell surface receptors
and activation of specific signal transduction pathways, without a
requirement for membrane channel formation.
VacA is reported to have an effect on eosinophils, mani-
fested as upregulated expression of chemokines (Figure 2G) (Kim
et al., 2007). This effect is reported to occur via a pathway
involving calcium influx, mitochondrial generation of reactive
oxygen intermediates, and NF-κB activation (Kim et al., 2007).
VacA also is reported to have effects on neutrophils, including
activation of p38 MAP kinase and increased expression of COX-2
(Boncristiano et al., 2003; Brest et al., 2006).
TARGETING THE POWER SOURCE: VacA AS A
MITOCHONDRIAL-ACTING TOXIN
One of the most intriguing and highly studied activities asso-
ciated with VacA over the past 10 years, is the capacity of the
toxin to target and modulate the properties of mitochondria
within host cells (Figure 2C). In addition to the well-known
role of mitochondria in central metabolism, this organelle has
emerged as a central hub of regulation for many of the most
fundamental cellular processes, including programmed cell death,
progression of the cell cycle, and innate immune sensing. At the
same time, it is now clear that a loss of mitochondrial func-
tion, or dysfunction, has been associated with perhaps hundreds
of human diseases and disorders. However, the extent to which
mitochondrial function is altered during infection of host cells
with pathogenic microbes as well as the possible consequences of
pathogen-mediated mitochondrial dysfunction, are both poorly
understood. This is a particularly relevant issue because sev-
eral dozen pathogenic bacteria and viruses have been reported
to generate protein effectors that localize to mitochondria
(Blanke, 2005).
MITOCHONDRIAL DYSFUNCTION IS A CHARACTERISTIC OF
VacA CELLULAR INTOXICATION
VacA-mediated modulation of mitochondrial function was first
reported approximately a decade after the toxin was discovered as
the factor within H. pylori culture filtrates that induces vacuola-
tion within cultured epithelial cell lines (Leunk et al., 1988). VacA
intoxication of human gastric epithelial AZ-521 cells was reported
to induce mitochondrial dysfunction (Figure 2C), as manifested
by a drop in cellular ATP levels, mitochondrial transmembrane
potential (m), and oxygen consumption (Kimura et al., 1999).
Since this first report, VacA-dependent alterations in mitochon-
dria, and in particular m dissipation, have been confirmed
independently by several groups (Galmiche et al., 2000; Willhite
and Blanke, 2004; Yamasaki et al., 2006; Calore et al., 2010;
Domanska et al., 2010; Foo et al., 2010), and are considered as
one of the primary consequences of toxin activity at mitochondria
(Blanke, 2005; Galmiche and Rassow, 2010; Rassow, 2011).
CONSEQUENCES OF VacA-DEPENDENT MITOCHONDRIAL
DYSFUNCTION
Because of the central importance of mitochondria in cellular
metabolism, it is perhaps not be surprising that VacA-mediated
mitochondrial dysfunction has distinct consequence for host
cells. In general, mitochondrial health is dependent on the
functional integrity of the organelle’s inner and outer mem-
branes, which have distinct biochemical and functional proper-
ties. Increased permeability can result in depolarization of the
mitochondrial inner membrane, leading tom dissipation and
a loss of metabolism (Figure 2C), which as indicated above,
occurs characteristically within VacA intoxicated cells (Galmiche
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et al., 2000; Willhite and Blanke, 2004; Yamasaki et al., 2006;
Calore et al., 2010; Domanska et al., 2010; Foo et al., 2010).
Increased outer membrane permeability (MOMP) results in the
release of pro-apoptotic protein effectors from the inner mem-
brane space into the cytosol (Blanke, 2005). Several studies have
reported the release of mitochondrial cytochrome c within cells
intoxicated with VacA (Galmiche et al., 2000; Willhite et al.,
2003, 2004; Yamasaki et al., 2006), resulting in apoptotic cell
death, which has been demonstrated to be a consequence of VacA
intoxication (Smoot et al., 1996; Kuck et al., 2001; Cover et al.,
2003).
WHERE IN THE CELL DOES VacA ACT TO INDUCE
MITOCHONDRIAL DYSFUNCTION?
The case for VacA as a mitochondrial-targeting toxin
VacA-mediated changes in mitochondrial properties could result
as an indirect consequence of vacuole formation, or potentially
from VacA action at the cell surface. However, the discovery that
the amino-terminal p33 domain (but not the carboxyl-terminal
p55 domain) of VacA localized to mitochondria when expressed
ectopically within mammalian cells suggested a different possibil-
ity, that at least the p33 fragment might be hardwired to localize
to mitochondria from the cytosol of mammalian cells (Galmiche
et al., 2000).
Several groups have now demonstrated that subsequent to
uptake into epithelial cells, full-length VacA toxin from H. pylori
partially localizes to mitochondria, as shown by both fluorescence
imaging and biochemical fractionation (Willhite and Blanke,
2004; Yamasaki et al., 2006; Oldani et al., 2009). The impor-
tance of VacA mitochondrial localization for toxin dependent
cell death has been questioned based on the observation that a
large fraction of VacA remains associated with endocytic com-
partments (Yamasaki et al., 2006). However, disrupting VacA
intracellular trafficking with the actin-disrupting agent cytocha-
lasin D prevented VacA localization to mitochondria, as well as
toxin-dependent m dissipation and cell death (Willhite and
Blanke, 2004; Oldani et al., 2009). Likewise, in cells transfected
with CagA, VacA was prevented from trafficking tomitochondria,
and VacA intoxicated cells were protected from toxin-dependent
apoptosis, further supporting the idea that VacA exerts its bio-
chemical activity directly at mitochondria (Willhite and Blanke,
2004; Oldani et al., 2009).
An inside job? VacA localizes to the mitochondrial inner
membrane
When p33 was expressed as a fusion with GFP within transiently
transfected mammalian cell lines, ultrastructural immunocyto-
chemistry studies using transmission electron microscopy pro-
vided images showing that a substantial fraction of the fusion
protein clearly localizes in the interior of mitochondria (Galmiche
et al., 2000). Perhaps more convincing have been studies using
isolated mitochondria, which have demonstrated that VacA is
imported beyond the outer membrane, but probably not past
the inner membrane (Galmiche et al., 2000; Domanska et al.,
2010; Foo et al., 2010). Together, these studies support a model
that the site of action of VacA is the mitochondrial inner
membrane.
Turning off the power: how does VacA cause mitochondrial
dysfunction?
The exact mechanism by which VacA induces mitochondrial dys-
function remains to be determined. Several studies have indicated
that mutant forms of VacA with disrupted membrane chan-
nel activity are attenuated in their capacity to induce m
dissipation, as well as cytochrome c release and other down-
stream changes associated with apoptosis within intact cells
(Figure 2C) (Willhite and Blanke, 2004) or isolated mitochon-
dria (Yamasaki et al., 2006). In studies conducted with intact
cells, mutant forms of VacA with point mutations (P9A, G14A)
that attenuated channel activity were taken into cells and local-
ized to mitochondria (Willhite and Blanke, 2004). These data
strongly support a model that subsequent to mitochondrial
import, VacA inserts into the mitochondrial inner membrane
and forms ion-conducting channels to cause membrane depo-
larization, resulting in m dissipation and a loss in ATP pro-
duction. Many aspects of this model remain to be evaluated,
including the intriguing question of how VacA channels at mito-
chondria alone might result in what appears to be widespread
m dissipation throughout the cell. It also remains to be
seen whether or not VacA recognizes and/or interacts with a
mitochondrial-specific protein or lipid localized to the mito-
chondrial inner membrane to facilitate membrane insertion and
channel formation.
Break-in: how does VacA breach the mitochondrial outer
membrane
While some AB toxins possess the remarkable ability to translo-
cate an active fragment across host cell membranes, there is
no indication that VacA facilitates its own entry past the mito-
chondrial outer membrane and ultimately to the inner mem-
brane. Rather, recent work (Domanska et al., 2010) suggests
that VacA translocation across mitochondrial outer membranes
may require toxin-exploitation of existing and highly conserved
protein import machinery. Studies with isolated mitochon-
dria revealed that the mitochondrial import receptor Tom20 is
involved in the uptake of p33, potentially reflecting the capacity
of Tom20 to interact with the hydrophobic residues of precursor
proteins (Abe et al., 2000). Subsequent transport of p33 across the
mitochondrial outer membrane was found to be mediated by the
general import pore formed by Tom40.
HOW DOES INTRACELLULAR VacA TARGET MITOCHONDRIA?
Does VacA mimic endogenous proteins destined for mitochondrial
import?
Mitochondria-localized proteins are generally hardwired
with targeting sequences embedded within their amino-acid
sequences. However, VacA does not possess an easily identifiable
mitochondrial-targeting motif. Fluorescence imaging studies
revealed that when expressed as GFP fusions in transiently
transfected cells, p33, but not p55, localized to mitochondria
(Galmiche et al., 2000). The sufficiency of the amino-terminal
p33 domain for mitochondrial localization within cells has been
confirmed independently (Domanska et al., 2010).
However, themolecular basis by which VacA targetsmitochon-
dria appears to be complex. One study showed that that neither
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the first 100 nor 200 amino-terminal residues were sufficient to
target a amino-terminally fused green fluorescence protein (GFP)
expressed ectopically or microinjected into the cytosol of cells to
intracellular mitochondria (Galmiche et al., 2000). On the other
hand, another study showed that the amino-terminal 34 residues,
comprising a highly hydrophobic sub-domain, is sufficient to
promote mitochondrial localization when expressed ectopically
as a fusion-protein with carboxyl-terminal GFP (Domanska et al.,
2010). The reasons underlying the differences between these two
studies are unclear, but may originate in the different orientation
of the GFP fusion proteins between the two studies.
AN ALTERNATIVE MODEL FOR VacA LOCALIZATION TO
MITOCHONDRIA
DOES VacA ENTER THE CYTOSOL DURING INTRACELLULAR
TRANSPORT?
The earliest studies to define the molecular basis of VacA local-
ization to mitochondria employed fragments or mutant forms
of the toxin either microinjected or expressed within the cytosol
of transiently transfected cells (Galmiche et al., 2000). These
approaches are clearly useful for interrogating VacA within the
cytosol. Nonetheless, there is a lack of experimental evidence for
cytosolic VacA within cells exposed to exogenous toxin. One of
the earliest papers to consider the intracellular trafficking of VacA
(Garner and Cover, 1996) reported VacA, as detected by indirect
immunofluorescence microscopy, located in a perinuclear region,
but not associated with cytotoxin-induced vacuoles, although
later studies using higher resolution techniques indicated that
VacA is in fact detectable in vacuoles (Li et al., 2004).
Subsequent studies of intracellular trafficking revealed VacA
within small punctate vesicles just after uptake from the cell sur-
face (Gauthier et al., 2004, 2005, 2007; Gupta et al., 2008, 2010)
and at later time points, localized to epinuclear structures con-
firmed to be mitochondria (Willhite and Blanke, 2004; Oldani
et al., 2009). Although it can be perilous to base a model par-
tially on “negative data,” the lack of evidence that VacA enters
the cytosolic compartment after uptake from the cell surface sug-
gests that VacA cellular activity does not require either VacA or a
fragment of VacA to be first translocated to the cytosol.
The unusual intracellular routing of VacA
If the intracellular action of VacA indeed does not require the
toxin to become cytosolic, then other mechanisms must be
considered to explain localization of the toxin to mitochondria
subsequent to cellular uptake. One alternative mechanism could
conceivably depend the transport of VacA-containingmembrane-
bound compartments from the cell surface to mitochondria. To
our knowledge, a well-defined pathway for the transport of any
component from the cell surface to mitochondria has not been
defined.
Studies of VacA intracellular transport have failed thus far to
produce evidence that VacA exploits either the acidic environ-
ment of late endosomal compartments or the ERAD pathway
to target mitochondria. Instead, work over the past decade has
indicated that VacA is taken up and trafficked by an unusual
pinocytic mechanism that had not previously been described
for other intracellular acting bacterial exotoxins (Figure 2B).
Specifically, VacA is internalized into epithelial cell lines by
a Cdc42-dependent pinocytic mechanism, and is trafficked to
late endosomal/lysosomal compartments (Molinari et al., 1997;
Papini et al., 1997; McClain et al., 2000; Gauthier et al., 2004,
2005, 2007). As the first step during cellular intoxication, VacA
binds to the plasma membrane of sensitive cells (Garner and
Cover, 1996), analogous to other intracellular-acting bacterial
toxins (Blanke, 2005). Recently, sphingomyelin (SM) has been
identified as a plasma membrane receptor that confers cellu-
lar sensitivity to VacA by binding the toxin to the cell sur-
face (Gupta et al., 2008). Moreover, VacA-SM interactions were
demonstrated to be required for Cdc42-dependent pinocytic
uptake from the plasma membrane and trafficking of VacA
(Gupta et al., 2010).
What is the molecular GPS for VacA localization to mitochondria?
The relationship between VacA intracellular trafficking and mito-
chondrial localization remains poorly understood. It is tempting
to speculate that the unusual aspects of VacA uptake and trans-
port from the cell surface specifically promote, and perhaps
are even required for toxin transport to cellular mitochondria,
although this idea remains to be formally tested. One recent
study implicated the pro-death, multi-domain Bcl-2 proteins Bax
and Bak, as essential for the intracellular positioning of VacA-
containing endocytic compartments in close juxtaposition with
mitochondria (Figure 2C) (Calore et al., 2010). In the absence
of Bax/Bak, VacA-containing vesicles were not observed to local-
ize with mitochondria. Likewise, vesicles coated with Bax or
Bak were not observed to be associated with mitochondria in
cells unless the cells had been intoxicated with VacA. This was
an unexpected observation, as neither Bax nor Bak were previ-
ously considered to have a functional role in endocytic vesicle
trafficking.
Bax/Bak was previously reported to be important for VacA-
mediated cell death (Yamasaki et al., 2006), but these new findings
suggest a potentially expanded and novel role for these two
molecules in the targeting and/or docking of VacA-containing
transport vesicles with mitochondria. The exact mechanisms
by which Bax/Bak induce the spatial juxtaposition of VacA-
containing endosomal compartments with mitochondria, or the
possible contributions of either of these two endogenous effec-
tors to VacA translocation to the mitochondrial inner membrane
are potentially exciting areas of future enquiry. One intriguing
possibility is that Bax and Bak promote membrane fusion
between mitochondria and the VacA-containing vesicles, allow-
ing VacA to localize to the inner membrane without having to
dissociate from one membrane to insert into a second membrane.
However, such a scenario has not yet been tested.
MITOCHONDRIAL TARGETING AND EPITHELIAL REMODELING
BY VacA
The issue of why VacA targets mitochondria remains an intrigu-
ing question. The multiple important roles of mitochondria
for cellular function suggest that VacA-dependent alterations in
mitochondria would have consequences for gastric epithelial cells.
As discussed above, an increase in apoptotic cells within the gas-
tric epithelium is a hallmark of persistent H. pylori infection, and
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VacA has been demonstrated to be essential and sufficient among
H. pylori factors for inducing cell death. But is VacA action at
mitochondria linked to cell death?
Recent studies have provided new insights into how VacA
action at mitochondria might be functionally associated with cell
death. VacA was demonstrated to disrupt mitochondrial dynam-
ics (Figure 2C) (Jain et al., 2011), which is the cellular balance
between mitochondrial fission and fusion, the two processes that
together control mitochondrial morphology, quality control, and
energy transduction. VacA-mediated disruption of mitochondrial
dynamics required hyperactivation of dynamin-related protein
1 (Drp1), which is a master regulator of mitochondrial fission,
and Drp1 activation, in turn, was essential for activation of
Bax, thereby committing VacA intoxicated cells to undergoing
apoptosis. Thus, the discovery of VacA-mediated activation of
Drp1 provides the direct molecular link between VacA action at
mitochondria and toxin-dependent cell death.
The mechanism by which VacA induces Drp1 is not clear.
VacA-mediated dissipation of mitochondrial transmembrane
potential (m) may induce Drp1 activation indirectly, as mito-
chondrial depolarization has previously been shown in unrelated
studies to induce calcineurin-mediated dephosphorylation of
Drp1 as a mechanism to drive Drp1 translocation to mitochon-
dria (Cereghetti et al., 2008). On the other hand, the possibility
that VacAmay act more directly to activate Drp1 cannot currently
be ruled out.
FINE-TUNING THE HOST PATHOGEN INTERFACE:
SYNERGISTIC AND ANTAGONISTIC ASSOCIATIONS
BETWEEN THE VacA EXOTOXIN AND CagA, THE TYPE
IV EFFECTOR OF H. pylori
Bacterial toxins are most typically studied as purified proteins in
order to best tease out their specific contributions to modulation
of host cell function. While often appropriate, these approaches
do not take into account possible functional interactions that may
exist between virulence factors. CagA is an important H. pylori
virulence factor, and analogous to vacA, specific cagA alleles
are highly predictive for the incidence and severity of disease
associated with H. pylori infection. Like VacA, CagA modulates
host cell function in several ways, primarily by disrupting signal
transduction within intoxicated cells.
In principle, VacA and CagA are fundamentally different in
their contributions to modulating the host epithelium. CagA, as
a Type IV effector injected directly into the eukaryotic cytosol,
modulates the functional properties of only those cells with which
H. pylori have specifically colonized. In contrast, secreted VacA
can act both proximally at the site of bacterial attachment to the
epithelial membrane, as well as distally upon uninfected epithe-
lial cells after diffusion from the site of adherent bacteria. Thus,
infected epithelial cells would be predicted to be subject to the
modulating effects of both VacA and CagA (Figure 3). There is
some evidence that some the cellular modulatory effects of VacA
and CagA might be synergistic. For example, a recent report sug-
gests that VacA and CagA may both facilitate iron acquisition
of H. pylori colonizing the apical surface of polarized epithelial
monolayers (Tan et al., 2011), without severely damaging the host
cells.
However, most studies to date however indicate that the cellu-
lar activities of VacA and CagA are primarily antagonistic. VacA
and CagA inhibit each other’s effects on epithelial cells (Argent
et al., 2008), with CagA down-regulating cellular vacuolation
(Figure 3), and VacA down-regulating the hummingbird phe-
notype of gastric epithelial cells associated with CagA injection.
Another report demonstrated that whereas CagA activates the
NFAT pathway via activation of calcineurin, VacA blocks cal-
cineurin activation through decreased calcium influx, thereby
down-regulating the NFAT pathway (Yokoyama et al., 2005).
Strikingly, the capacity of VacA to induce the death of epithe-
lial cells is blocked by CagA (Figure 3) (Oldani et al., 2009).
The authors demonstrated phosphorylated CagA blocks the abil-
ity of VacA to traffic to intracellular compartments, whereas
unphosphorylated CagA blocks apoptosis in a manner that mim-
ics Bcl2 (an anti-apoptotic factor) overexpression. CagA fur-
ther inhibits VacA-dependent apoptosis by blocking the cellular
uptake of VacA from the cell surface (Akada et al., 2010).
Increasing evidence suggests that VacA and CagA can func-
tionally interact in manner that directly affects disease outcome.
This idea is supported by epidemiological studies revealing sig-
nificant 3-way associations between vacA alleles, cagA alleles, and
the development of gastric diseases, including cancer (van Doorn
et al., 1999; Yamazaki et al., 2005; Jang et al., 2010; Jones et al.,
2011).
How might VacA and CagA function together to promote
colonization and disease? A recent study of the molecular evolu-
tion of vacA indicates that the vacA gene and the core H. pylori
genome do not share the same evolutionary history (Gangwer
et al., 2010). The vacA and cagA genes are separated on the
H. pylori genome by a considerable distance, and several lines
of evidence suggest that the cag PAI was acquired more recently
than vacA (Gressmann et al., 2005; Olbermann et al., 2010).
This type of evolutionary history might support the idea that
acquisition of the genes encoding VacA and CagA established
the pro-/anti-inflammatory and pro-/anti-apoptotic balance nec-
essary to promote long-term colonization of the human gastric
mucosa.
Overall, these findings are consistent with the idea that VacA
and CagA most effectively promote H. pylori persistence by
functioning together in manner that remodels the gastric niche
occupied by the bacterium, but at the same time limits the degree
to which the epithelial mucosa is damaged. The capacity to limit
damage to host cells and tissues during infection is an increasingly
recognized strategy employed by a number of pathogenic bacte-
ria to fine tune virulence while promoting propagation and/or
persistence (Shames and Finlay, 2010).
VacA AS A HOST CELL REMODELER
VacA does not fit neatly into our current notions of intracellular-
acting bacterial exotoxins. Whether the p33 and p55 fragments of
VacA ultimately comprise the A and B fragments corresponding
to the AB architecture of most intracellular-acting toxins remains
to be seen. The absence of a defined enzymatic activity, as well
as the strong association of VacA membrane channel activity
with most of the toxin’s intracellular effects suggests that VacA
does not rely on the power of catalytic turnover to modulate
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FIGURE 3 | Synergistic and antagonistic interactions between
VacA and CagA. (A) CagA blocks intracellular trafficking of VacA
[Oldani et al. (2009)], thereby inhibiting VacA-mediated vacuolation and
apoptosis [Argent et al. (2008); Oldani et al. (2009)]. VacA-dependent
apoptosis is further antagonized by CagA activation of Bcl-2 [Oldani et al.
(2009)]. (B) VacA prevents CagA-mediated activation of ERK1/2 and
hummingbird-like cellular morphological changes by misrouting
the epidermal growth factor receptor (EGFR) [Tegtmeyer et al. (2009)].
VacA also counteracts the ability of CagA to activate NFAT, which
has multiple roles in cell growth and differentiation [Yokoyama et al.
(2005); Oldani et al. (2009)]. (C) CagA disruption of epithelial tight
junctions (TJ) allows VacA to access underlying immune cells. (D) VacA
and CagA collaborate to misdirect holotransferrin to H. pylori
micro-colonies at the apical surface.
host cells. Because toxin translocation from membrane bound
compartments is generally considered a highly inefficient process,
an intriguing question remains how VacA intracellular activity
is mediated by channel activity at mitochondria. As suggested
by recent work into the mechanism underlying the uptake and
transport of VacA, perhaps VacA activity does not require toxin
translocation across a membrane, but perhaps, instead, delivery
by a mechanism involving membrane fusion between VacA intra-
cellular transport vesicles and mitochondria.
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